Drug Shortage Report for MAGNESIUM SULFATE INJECTION USP
Report ID | 184959 |
Drug Identification Number | 00392618 |
Brand name | MAGNESIUM SULFATE INJ 20% USP |
Common or Proper name | MAGNESIUM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MAGNESIUM SULFATE |
Strength(s) | 200MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10ML |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-02 |
Estimated end date | 2023-07-21 |
Actual end date | 2023-07-24 |
Shortage status | Resolved |
Updated date | 2023-07-25 |
Company comments | Baxter item: 5421. Product is available on allocation based on 150% of historical volumes. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-07-25 | English | Compare |
v7 | 2023-07-24 | French | Compare |
v6 | 2023-07-24 | English | Compare |
v5 | 2023-06-28 | French | Compare |
v4 | 2023-06-28 | English | Compare |
v3 | 2023-02-16 | French | Compare |
v2 | 2023-02-16 | French | Compare |
v1 | 2023-02-16 | English | Compare |
Showing 1 to 8 of 8